Diamyd Medical AB (publ) (DMYD-B.ST)

SEK 16.12

(2.54%)

Long Term Debt Summary of Diamyd Medical AB (publ)

  • Diamyd Medical AB (publ)'s latest annual long term debt in 2024 was 30.67 Million SEK , up 93.33% from previous year.
  • Diamyd Medical AB (publ)'s latest quarterly long term debt in 2024 Q4 was 30.67 Million SEK , down -2.85% from previous quarter.
  • Diamyd Medical AB (publ) reported annual long term debt of 15.86 Million SEK in 2023, down 0.0% from previous year.
  • Diamyd Medical AB (publ) reported annual long term debt of - SEK in 2022, down 0.0% from previous year.
  • Diamyd Medical AB (publ) reported quarterly long term debt of 30.67 Million SEK for 2024 Q4, down -2.85% from previous quarter.
  • Diamyd Medical AB (publ) reported quarterly long term debt of 24.14 Million SEK for 2024 Q1, up 52.21% from previous quarter.

Annual Long Term Debt Chart of Diamyd Medical AB (publ) (2024 - 2010)

Historical Annual Long Term Debt of Diamyd Medical AB (publ) (2024 - 2010)

Year Long Term Debt Long Term Debt Growth
2024 30.67 Million SEK 93.33%
2023 15.86 Million SEK 0.0%
2022 - SEK 0.0%
2021 - SEK 0.0%
2020 - SEK 0.0%
2019 - SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%
2016 - SEK 0.0%
2015 - SEK 0.0%
2014 - SEK 0.0%
2013 - SEK 0.0%
2012 - SEK 0.0%
2011 - SEK 0.0%
2010 - SEK 0.0%

Peer Long Term Debt Comparison of Diamyd Medical AB (publ)

Name Long Term Debt Long Term Debt Difference
Alligator Bioscience AB (publ) 7.51 Million SEK -308.089%
Ziccum AB (publ) 286 Thousand SEK -10624.476%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 2.15 Million SEK -1325.279%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 850 Thousand SEK -3508.471%
Genovis AB (publ.) 74.8 Million SEK 58.999%
Intervacc AB (publ) 142 Thousand SEK -21500.0%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK -Infinity%
Active Biotech AB (publ) 3 Million SEK -922.4%
Magle Chemoswed Holding AB (publ) 32.58 Million SEK 5.862%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) - SEK -Infinity%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 65.23 Million SEK 52.984%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 4.29 Million SEK -613.966%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -7133.962%
Egetis Therapeutics AB (publ) 103.4 Million SEK 70.337%
Karolinska Development AB (publ) - SEK -Infinity%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) - SEK -Infinity%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK -2967.2%
Calliditas Therapeutics AB (publ) 939.5 Million SEK 96.735%
Camurus AB (publ) 13.61 Million SEK -125.314%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 24.51 Million SEK -25.136%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 844.9 Million SEK 96.37%
Cyxone AB (publ) 74 Thousand SEK -41348.649%
ExpreS2ion Biotech Holding AB (publ) 1.43 Million SEK -2035.933%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 31.94 Million SEK 3.991%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 136 Thousand SEK -22452.941%
SynAct Pharma AB 58 Thousand SEK -52782.759%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK -3508.471%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK -1641.738%
BioInvent International AB (publ) 14.53 Million SEK -111.022%
Alzinova AB (publ) 800 Thousand SEK -3734.0%
Oncopeptides AB (publ) 106.48 Million SEK 71.196%
Pila Pharma AB (publ) - SEK -Infinity%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 66.198%
Xbrane Biopharma AB (publ) 112.89 Million SEK 72.832%
Ascelia Pharma AB (publ) 176 Thousand SEK -17327.273%
Diagonal Bio AB (publ) - SEK -Infinity%